Literature DB >> 20484898

Cellulose triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration.

Shuangxin Liu1, Wei Shi, Xinling Liang, Yong Su, Yongzhen Liang, Bin Zhang, Zhiming Ye, Lixia Xu, Yunfeng Xia, Chaoshen He, Jianchao Ma, Yiming Tao, Hen Ye, Hui Li.   

Abstract

Thrombocytopenia is a common complication in patients receiving continuous veno-venous hemofiltration (CVVH) in the intensive care unit. The hemofilter itself plays an important role in the genesis of thrombocytopenia. The present study was undertaken to test whether there were differences in platelet loss and activation during CVVH with a polysulfone (PS) hemofilter or a cellulose triacetate (CTA) dialyzer. 96 patients with thrombocytopenia and acute kidney injury requiring CVVH were randomly assigned to four groups receiving low-molecular-weight heparin (LMWH) PS (n = 24), LMWH CTA (n = 24), no anticoagulation PS (n = 24), and no anticoagulation CTA (n = 24), respectively. We found a significant decrease in platelet counts, but an increased platelet activation with the PS hemofilter in patients who received no anticoagulation. There was no significant decrease in platelet counts and activation in the CTA group. The cellulose membranes could be an effective alternative to the standard synthetic membranes in patients at high risk for thrombocytopenia during CVVH. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484898     DOI: 10.1159/000314649

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

1.  Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis.

Authors:  Andrea Urbani; Vittorio Sirolli; Santina Lupisella; Stefano Levi-Mortera; Barbara Pavone; Luisa Pieroni; Luigi Amoroso; Roberto Di Vito; Sonia Bucci; Sergio Bernardini; Paolo Sacchetta; Mario Bonomini
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

2.  Thrombogenicity and long-term cytokine removal capability of a novel asymmetric triacetate membrane hemofilter.

Authors:  Andreas Körtge; Thomas Wild; Benjamin Heskamp; Manuel Folk; Steffen Mitzner; Reinhold Wasserkort
Journal:  J Artif Organs       Date:  2018-07-24       Impact factor: 1.731

3.  Resolution of dialyzer membrane-associated thrombocytopenia with use of cellulose triacetate membrane: a case report.

Authors:  Feyisayo Olafiranye; Win Kyaw; Oladipupo Olafiranye
Journal:  Case Rep Med       Date:  2011-04-10

Review 4.  Examining hemodialyzer membrane performance using proteomic technologies.

Authors:  Mario Bonomini; Luisa Pieroni; Lorenzo Di Liberato; Vittorio Sirolli; Andrea Urbani
Journal:  Ther Clin Risk Manag       Date:  2017-12-18       Impact factor: 2.423

5.  Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study.

Authors:  Buyun Wu; Dehua Gong; Bin Xu; Qunpeng He; Zhihong Liu; Daxi Ji
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.